SCHEMBL6169437

SCHEMBL6169437

CSc1ccc(C=C(C(C)=NO)c2ccccc2)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C1 Q04828 6/20 0.66
AKR1C2 P52895 5/20 0.66
AKR1C3 P42330 4/20 0.66
KMT2A Q03164 6/20 0.44
MAPT P10636 5/20 0.44
MEN1 O00255 4/20 0.44
KDM4E B2RXH2 4/20 0.40
NPC1 O15118 4/20 0.40
RAB9A P51151 4/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
NFKB1 P19838 2/20 0.40
NFKB2 Q00653 2/20 0.40
RELA Q04206 2/20 0.40
ALDH1A1 P00352 3/20 0.39
PTGS2 P35354 1/20 0.39
POLB P06746 2/20 0.39
NSD2 O96028 1/20 0.39
GAA P10253 1/20 0.39
RECQL P46063 1/20 0.39
MCL1 Q07820 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6169433 1.00 AKR1C1 (0.66) AKR1C1AKR1C2AKR1C3KMT2AMAPT
SCHEMBL8473609 0.94 AKR1C3 (0.57) AKR1C1AKR1C2AKR1C3KMT2AMAPT
SCHEMBL8473605 0.94 AKR1C3 (0.57) AKR1C1AKR1C2AKR1C3KMT2AMAPT
SCHEMBL6169883 0.85 AKR1C1 (0.55) AKR1C1AKR1C2AKR1C3KMT2AMAPT
SCHEMBL6169877 0.85 AKR1C1 (0.55) AKR1C1AKR1C2AKR1C3KMT2AMAPT
SCHEMBL6520441 0.85 AKR1C3 (0.48) AKR1C1AKR1C2AKR1C3KMT2AMAPT
SCHEMBL6520446 0.85 AKR1C3 (0.48) AKR1C1AKR1C2AKR1C3KMT2AMAPT
SCHEMBL6516514 0.81 AKR1C3 (0.44) AKR1C1AKR1C2AKR1C3KMT2AMAPT
SCHEMBL6516511 0.81 AKR1C3 (0.44) AKR1C1AKR1C2AKR1C3KMT2AMAPT
SCHEMBL6169890 0.81 AKR1C1 (0.79) AKR1C1AKR1C2AKR1C3KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1528059-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle LLC (US) 2005-05-04 EP disclosed
EP-0809636-B1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2002-09-04 EP disclosed
EP-1223167-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle & Co. (US) 2002-07-17 EP disclosed
US-5859257-A ANTIINFLAMMATORY, ANTIARTHRITIC AGENTS G. D. SEARLE & CO. (US) 1999-01-12 US disclosed
EP-0809636-A1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-12-03 EP disclosed
WO-1996025405-A1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-08-22 WO disclosed